Navigation Links
Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG
Date:2/17/2009

TORONTO, Feb. 17 /PRNewswire/ - Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and software and Siemens Healthcare today announced an OEM Distribution Agreement for Sentinelle's Vanguard(R) coils. Under this agreement, Siemens will sell the "Sentinelle Vanguard for Siemens" coil for the MRI family members MAGNETOM(R) Espree, MAGNETOM(R) Avanto and MAGNETOM(R) Symphony, A Tim(TM) System. The Sentinelle Vanguard for Siemens is also integrated into the new MAGNETOM Espree - Pink, a dedicated system devoted to excellence in MR Breast Care. The Agreement also anticipates future development collaborations.

Breast cancer is the most frequently diagnosed cancer in women. In 2008, 182,460 new cases were diagnosed and 40,480 women died of breast cancer in the US(1). The National Cancer Institute estimates that a woman has a 1-in-8 chance of developing breast cancer during her lifetime. The American Cancer Society's new screening guidelines will impact up to one million high-risk women by recommending they receive additional annual MRI screenings. A high percentage of these women will benefit from breast MRI.

The Sentinelle Vanguard for Siemens enables excellent quality MR images of the breast and provides complete and open access for intervention with an award winning design that optimizes patient comfort and workflow. The coil is designed with Variable Coil Geometry(TM) (VCG) that allows the coil to accommodate a wide range of patient sizes, and increases signal-to-noise ratio delivering excellent image quality.

Integration into Siemens' MAGNETOM Espree - Pink

MAGNETOM Espree - Pink combines the 70cm Open-Bore design of the MAGNETOM Espree with the Sentinelle Vanguard solution. The breast coil offers exceptional breast imaging and biopsy access. MAGNETOM Espree - Pink offers unmatched patient comfort, and an innovative workflow pushing MRI Breast Care to the next level.

"Patients are always nervous during breast MRI examinations and biopsies. The biggest advantage in using MAGNETOM Espree and the Sentinelle system is the wide open access," said Jae K. Kim, MD, PhD, Radiology Limited, Tuscon, Arizona.

"Sentinelle is dedicated to improving breast cancer management, healthcare outcomes and patient experience." said Cameron Piron, Sentinelle's President and CEO. "We are extremely pleased to be working with a market leader like Siemens. With this latest distribution agreement, even more women will have access to leading-edge MRI technology."

"The Sentinelle Vanguard for Siemens provides renowned technology for both imaging and biopsy. This benefits the customer by offering excellent image quality, optimized biopsy access for increased accuracy, and fast examination times for higher patient throughput," said Walter Märzendorfer, head of Magnetic Resonance, Siemens Healthcare.

About Sentinelle Medical Inc.

Sentinelle Medical is dedicated to improving patient care with early detection and accurate intervention. The company researches, develops, manufactures, sells and supports leading edge Magnetic Resonance Imaging (MRI) technologies. The ground breaking Sentinelle Vanguard(R) breast coils provide excellent quality MR images, complete and open access for intervention and award winning design that optimizes patient comfort and workflow. Sentinelle products are used in leading breast cancer and imaging sites throughout North America including Dartmouth-Hitchcock Medical Centre, H. Lee Moffitt Cancer Center and Research Institute (University of South Florida), Mountain Medical Physician Specialists, Radiology Ltd., Scripps Memorial Hospital, Sunnybrook Health Sciences Centre, University Health Network and Windsong Radiology Group. Sentinelle Medical is a privately owned Canadian company.

For more information, visit www.sentinellemedical.com.

About Siemens Healthcare

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

    -------------------------------
    (1) American Cancer Society, 2008


'/>"/>
SOURCE Sentinelle Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sentinelle Medical Enters OEM Distribution Agreement with Toshiba
2. Dr. Teresa Bartlett Joins Sedgwick CMS as Medical Director
3. St. Mary Medical Center Opens New Cardiovascular Catheterization Labs Reaffirming Role as a Regional Leader in Cardiovascular Medicine
4. Sick as a Dog: Pets Top Medical Conditions of 2008
5. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
6. Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services
7. PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil
8. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
9. New Website Coming Soon for Electronic Medical Transcription Company
10. Prescription Drug Information Site Offers Free Medical Marketing Opportunity to Healthcare Professionals
11. New Study Shares Benchmarks for Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: